Eppendorf acquires centrifuge biz of Koki Holdings

Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf will acquire Koki’s centri...

March 20, 2020 | Friday | News
Japan approves Novartis' SMA drug

Novartis Pharma has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved Zolgensma (o...

March 19, 2020 | Thursday | News
Fujifilm invests $83M to expand microbial production capacity

Japan based FUJIFILM Corporation has announced that it will invest approximately 9 billion yen ($83M USD)...

March 19, 2020 | Thursday | News
Ribomic inks license agreement with Aju Pharma for AMD drug

Japan based RIBOMIC Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics has signed the li...

March 18, 2020 | Wednesday | News
Japan develops new strategy to treat oral cancer

Researchers at Okayama University in Japan have recently published a study in Cells in which they reduced the ...

March 17, 2020 | Tuesday | News
Heartseed collaborates with Itochu Chemical Frontier

Heartseed, a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for the treatment of heart failure...

March 13, 2020 | Friday | News
Japan to test AIM ImmunoTech’s Ampligen for COVID-19

AIM ImmunoTech, an immunopharmaceutical company focused on the development of immunological, viral and multiple cancer t...

March 10, 2020 | Tuesday | News
Nagase Medicals, Osaka University to work on drug delivery systems

NAGASE & CO., LTD. (NAGASE) and Osaka University have launched DDS Products Joint Development Research Cha...

March 6, 2020 | Friday | News
Takeda initiates development of Plasma-Derived Therapy for COVID-19

Japan based Takeda Pharmaceutical Company will share with members of the United States Congress that it is initiating th...

March 5, 2020 | Thursday | News
Saki Corporation opens new factory in Japan

Japan based Saki Corporation, an innovator in the field of automated optical and X-ray inspection equipment, announces t...

March 4, 2020 | Wednesday | News
Takeda to divest select assets to Hypera for $825M

Japan based Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a p...

March 3, 2020 | Tuesday | News
UCB, Daiichi Sankyo to offer new treatment option for epilepsy

UCB Japan Co., Ltd, and Daiichi Sankyo Company, Limited are pleased to announce that a supplemental application for VIMP...

March 2, 2020 | Monday | News
Takeda acquires PvP Biologics focusing on celiac disease treatment

Japan based Takeda Pharmaceutical Company Limited announced that it has acquired US based PvP Biologics, Inc. follo...

February 28, 2020 | Friday | News
Eisai, FUJI YAKUHIN to work on hyperuricemia and gout treatment

Japan based Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD.  have concluded a license agreement concerning dotinurad (ge...

February 27, 2020 | Thursday | News
Softbank leads $165 M funding for Karius

Japanese multinational conglomerate holding company SoftBank Group led the new funding round for US based firm...

February 26, 2020 | Wednesday | News
Eisai receives recognition for contribution towards liver diseases

Japan based pharmaceutical firm Eisai announced that it has received the President’s Award at the 8th Technology M...

February 25, 2020 | Tuesday | News
Eisai’s H3 Biomedicine appoints new CMO

H3 Biomedicine, Inc. (H3), precision medicine research & development subsidiary of Eisai Co has announced the a...

February 24, 2020 | Monday | News
BIO cancels Asia conference in Tokyo amid COVID-19 outbreak

The Biotechnology Innovation Organization (BIO) has announced, it is canceling the annual BIO Asia conference in Tokyo s...

February 24, 2020 | Monday | News